ID   POLG_HCVJF              Reviewed;        3033 AA.
AC   Q99IB8;
DT   10-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   18-JUN-2025, entry version 188.
DE   RecName: Full=Genome polyprotein;
DE   Contains:
DE     RecName: Full=Core protein precursor;
DE     AltName: Full=Capsid protein C;
DE     AltName: Full=p23;
DE     ... Deleted a lot of lines here ...
OS   Hepatitis C virus genotype 2a (isolate JFH-1) (HCV).
OC   Viruses; Riboviria; Orthornavirae; Kitrinoviricota; Flasuviricetes;
OC   Amarillovirales; Flaviviridae; Hepacivirus; Hepacivirus hominis.
OX   NCBI_TaxID=356411;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=11424123; DOI=10.1002/jmv.1055;
RA   Kato T., Furusaka A., Miyamoto M., Date T., Yasui K., Hiramoto J.,
RA   Nagayama K., Tanaka T., Wakita T.;
RT   "Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis
RT   patient.";
RL   J. Med. Virol. 64:334-339(2001).
CC   -!- FUNCTION: [Mature core protein]: Packages viral RNA to form a viral
CC       nucleocapsid, and promotes virion budding (Probable). Participates in
CC       the viral particle production as a result of its interaction with the
CC       non-structural protein 5A (PubMed:18524832). Binds RNA and may function
CC       as a RNA chaperone to induce the RNA structural rearrangements taking
CC       place during virus replication (By similarity). Modulates viral
CC       translation initiation by interacting with viral IRES and 40S ribosomal
CC       subunit (By similarity). Affects various cell signaling pathways, host
CC       immunity and lipid metabolism (Probable). Prevents the establishment of
CC       cellular antiviral state by blocking the interferon-alpha/beta (IFN-
CC       alpha/beta) and IFN-gamma signaling pathways and by blocking the
CC       formation of phosphorylated STAT1 and promoting ubiquitin-mediated
CC       proteasome-dependent degradation of STAT1 (By similarity). Activates
CC       STAT3 leading to cellular transformation (By similarity). Regulates the
CC       activity of cellular genes, including c-myc and c-fos (By similarity).
CC       May repress the promoter of p53, and sequester CREB3 and SP110 isoform
CC       3/Sp110b in the cytoplasm (By similarity). Represses cell cycle
CC       negative regulating factor CDKN1A, thereby interrupting an important
CC       check point of normal cell cycle regulation (By similarity). Targets
CC       transcription factors involved in the regulation of inflammatory
CC       responses and in the immune response: suppresses NF-kappa-B activation,
CC       and activates AP-1 (By similarity). Binds to dendritic cells (DCs) via
CC       C1QR1, resulting in down-regulation of T-lymphocytes proliferation (By
CC       similarity). Alters lipid metabolism by interacting with hepatocellular
CC       proteins involved in lipid accumulation and storage (By similarity).
CC       Induces up-regulation of FAS promoter activity, and thereby contributes
CC       to the increased triglyceride accumulation in hepatocytes (steatosis)
CC       (By similarity). {ECO:0000250|UniProtKB:P26662,
CC       ECO:0000250|UniProtKB:P26664, ECO:0000250|UniProtKB:P27958,
CC       ECO:0000250|UniProtKB:P29846, ECO:0000269|PubMed:18524832,
CC       ECO:0000305}.
CC   ... removed more lines here and in other headers ...
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB047639; BAB32872.1; -; Genomic_RNA.
DR   PDB; 2KZQ; NMR; -; A=684-719.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activation of host autophagy by virus;
KW   Apoptosis; ATP-binding; Capsid protein;
KW   Clathrin-mediated endocytosis of virus by host; Disulfide bond;
KW   Fusion of virus membrane with host endosomal membrane;
KW   Fusion of virus membrane with host membrane;
FT   INIT_MET        1
FT                   /note="Removed; by host"
FT                   /evidence="ECO:0000250|UniProtKB:P26664"
FT   CHAIN           2..3033
FT                   /note="Genome polyprotein"
FT                   /id="PRO_0000450856"
FT   CHAIN           2..191
FT                   /note="Core protein precursor"
FT                   /id="PRO_0000045592"
FT   CHAIN           2..177
FT                   /note="Mature core protein"
FT                   /id="PRO_0000045593"
FT   PROPEP          178..191
FT                   /note="ER anchor for the core protein, removed in mature
FT                   form by host signal peptidase"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT                   /id="PRO_0000045594"
FT   CHAIN           192..383
FT                   /note="Envelope glycoprotein E1"
FT                   /id="PRO_0000045595"
FT   CHAIN           384..750
FT                   /note="Envelope glycoprotein E2"
FT                   /id="PRO_0000045596"
FT   CHAIN           751..813
FT                   /note="Viroporin p7"
FT                   /id="PRO_0000045597"
FT   CHAIN           814..1030
FT                   /note="Protease NS2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01030"
FT                   /id="PRO_0000045598"
FT   CHAIN           1031..1661
FT                   /note="Serine protease/helicase NS3"
FT                   /id="PRO_0000045599"
FT   CHAIN           1662..1715
FT                   /note="Non-structural protein 4A"
FT                   /id="PRO_0000045600"
FT   CHAIN           1716..1976
FT                   /note="Non-structural protein 4B"
FT                   /id="PRO_0000045601"
FT   CHAIN           1977..2442
FT                   /note="Non-structural protein 5A"
FT                   /id="PRO_0000045602"
FT   CHAIN           2443..3033
FT                   /note="RNA-directed RNA polymerase"
FT                   /id="PRO_0000045603"
FT   TOPO_DOM        2..168
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        169..189
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        190..358
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   TRANSMEM        359..379
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   TOPO_DOM        380..729
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   TRANSMEM        730..750
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   TOPO_DOM        751..761
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000269|PubMed:29253880"
FT   TRANSMEM        762..782
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   TOPO_DOM        783..785
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   TRANSMEM        786..807
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   TOPO_DOM        808..817
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   TRANSMEM        818..838
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WMX2"
FT   TOPO_DOM        839..842
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WMX2"
FT   TRANSMEM        843..863
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WMX2"
FT   TOPO_DOM        864..885
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WMX2"
FT   TRANSMEM        886..906
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WMX2"
FT   TOPO_DOM        907..1661
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WMX2"
FT   TRANSMEM        1662..1682
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1683..1809
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1810..1830
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1831..1832
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   TRANSMEM        1833..1853
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1854
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1855..1875
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1876..1885
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1886..1906
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1907..1976
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        1977..2007
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   TOPO_DOM        2008..3012
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   TRANSMEM        3013..3033
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   DOMAIN          907..1030
FT                   /note="Peptidase C18"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01030"
FT   DOMAIN          1031..1212
FT                   /note="Peptidase S29"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01166"
FT   DOMAIN          1221..1373
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          2656..2774
FT                   /note="RdRp catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00539"
FT   REGION          2..75
FT                   /note="Disordered"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   REGION          2..59
FT                   /note="Interaction with DDX3X"
FT                   /evidence="ECO:0000250|UniProtKB:Q5EG65"
FT   REGION          2..58
FT                   /note="Interaction with EIF2AK2/PKR"
FT                   /evidence="ECO:0000250|UniProtKB:P26662"
FT   REGION          2..23
FT                   /note="Interaction with STAT1"
FT                   /evidence="ECO:0000250|UniProtKB:P26662"
FT   REGION          112..152
FT                   /note="Important for endoplasmic reticulum and
FT                   mitochondrial localization"
FT                   /evidence="ECO:0000250|UniProtKB:P26662"
FT   REGION          122..173
FT                   /note="Interaction with APOA2"
FT                   /evidence="ECO:0000250|UniProtKB:P29846"
FT   REGION          164..167
FT                   /note="Important for lipid droplets localization"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   REGION          265..296
FT                   /note="Important for fusion"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   REGION          385..411
FT                   /note="HVR1"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   REGION          484..496
FT                   /note="CD81-binding 1"
FT                   /evidence="ECO:0000250|UniProtKB:P26663"
FT   REGION          524..555
FT                   /note="CD81-binding 2"
FT                   /evidence="ECO:0000250|UniProtKB:P26663"
FT   REGION          664..675
FT                   /note="EIF2AK2/eIF2-alpha phosphorylation homology domain
FT                   (PePHD)"
FT   REGION          908..1210
FT                   /note="Protease NS2-3"
FT                   /evidence="ECO:0000250|UniProtKB:P26663"
FT   REGION          933..953
FT                   /note="Interaction with human SCPS1"
FT                   /evidence="ECO:0000269|PubMed:24009510"
FT   REGION          1481..1501
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1490..1501
FT                   /note="RNA-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P26663"
FT   REGION          1683..1694
FT                   /note="NS3-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   REGION          1837..1865
FT                   /note="Glycine zipper"
FT                   /evidence="ECO:0000269|PubMed:29167346"
FT   REGION          1982..2002
FT                   /note="Membrane-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   REGION          2009..2225
FT                   /note="D1; RNA-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   REGION          2124..2332
FT                   /note="Transcriptional activation"
FT                   /evidence="ECO:0000255"
FT   REGION          2124..2212
FT                   /note="FKBP8-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P26662"
FT   REGION          2139..2143
FT                   /note="Interaction with non-structural protein 4A"
FT                   /evidence="ECO:0000250|UniProtKB:P26662"
FT   REGION          2192..2213
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2210..2249
FT                   /note="ISDR"
FT                   /evidence="ECO:0000250|UniProtKB:P26662"
FT   REGION          2214..2275
FT                   /note="Interaction with EIF2AK2/PKR"
FT                   /evidence="ECO:0000250|UniProtKB:P26663"
FT   REGION          2227..2315
FT                   /note="D2"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   REGION          2228..2315
FT                   /note="Disordered"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   REGION          2249..2306
FT                   /note="NS4B-binding"
FT                   /evidence="ECO:0000255"
FT   REGION          2281..2297
FT                   /note="Interaction with human PPIA/CYPA"
FT                   /evidence="ECO:0000269|PubMed:21593166"
FT   REGION          2329..2442
FT                   /note="D3"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   REGION          2336..2447
FT                   /note="Interaction with host IFI27"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   REGION          2352..2432
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2358..2381
FT                   /note="V3"
FT   REGION          2371..2439
FT                   /note="Interaction with host VAPB"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   MOTIF           5..13
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:25485706"
FT   MOTIF           38..43
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:25485706"
FT   MOTIF           58..64
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:25485706"
FT   MOTIF           66..71
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:25485706"
FT   MOTIF           1320..1323
FT                   /note="DECH box"
FT                   /evidence="ECO:0000269|PubMed:30281972,
FT                   ECO:0000269|PubMed:31511391"
FT   MOTIF           2322..2325
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           2326..2334
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:P26662"
FT   COMPBIAS        7..16
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        32..47
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2196..2213
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2316..2326
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2355..2379
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2398..2408
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2417..2426
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        956
FT                   /note="For protease NS2 activity; shared with dimeric
FT                   partner"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01030"
FT   ACT_SITE        976
FT                   /note="For protease NS2 activity; shared with dimeric
FT                   partner"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01030"
FT   ACT_SITE        997
FT                   /note="For protease NS2 activity; shared with dimeric
FT                   partner"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01030"
FT   ACT_SITE        1087
FT                   /note="Charge relay system; for serine protease NS3
FT                   activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01166"
FT   ACT_SITE        1111
FT                   /note="Charge relay system; for serine protease NS3
FT                   activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01166"
FT   ACT_SITE        1169
FT                   /note="Charge relay system; for serine protease NS3
FT                   activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01166"
FT   BINDING         1127
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01166"
FT   BINDING         1129
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01166"
FT   BINDING         1175
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01166"
FT   BINDING         1179
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01166"
FT   BINDING         1234..1241
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   BINDING         1241
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic; for NS3 helicase activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WMX2"
FT   BINDING         1321
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic; for NS3 helicase activity"
FT                   /evidence="ECO:0000305|PubMed:30281972"
FT   BINDING         2015
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WMX2"
FT   BINDING         2033
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WMX2"
FT   BINDING         2035
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WMX2"
FT   BINDING         2056
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WMX2"
FT   BINDING         2662
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic; for RNA-directed RNA polymerase
FT                   activity"
FT                   /evidence="ECO:0000250|UniProtKB:P26663"
FT   BINDING         2760
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic; for RNA-directed RNA polymerase
FT                   activity"
FT                   /evidence="ECO:0000250|UniProtKB:P26663"
FT   BINDING         2761
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic; for RNA-directed RNA polymerase
FT                   activity"
FT                   /evidence="ECO:0000250|UniProtKB:P26663"
FT   SITE            177..178
FT                   /note="Cleavage; by signal peptide peptidase"
FT                   /evidence="ECO:0000250|UniProtKB:P26662"
FT   SITE            191..192
FT                   /note="Cleavage; by host signal peptidase"
FT                   /evidence="ECO:0000250|UniProtKB:P26662"
FT   SITE            383..384
FT                   /note="Cleavage; by host signal peptidase"
FT                   /evidence="ECO:0000250|UniProtKB:P26662"
FT   SITE            750..751
FT                   /note="Cleavage; by host signal peptidase"
FT                   /evidence="ECO:0000250"
FT   SITE            813..814
FT                   /note="Cleavage; by host signal peptidase"
FT                   /evidence="ECO:0000250"
FT   SITE            1030..1031
FT                   /note="Cleavage; by protease NS2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01030"
FT   SITE            1661..1662
FT                   /note="Cleavage; by serine protease/helicase NS3"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   SITE            1715..1716
FT                   /note="Cleavage; by serine protease/helicase NS3"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   SITE            1976..1977
FT                   /note="Cleavage; by serine protease/helicase NS3"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   SITE            2442..2443
FT                   /note="Cleavage; by serine protease/helicase NS3"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   MOD_RES         2
FT                   /note="N-acetylserine; by host"
FT                   /evidence="ECO:0000250|UniProtKB:Q913V3"
FT   MOD_RES         53
FT                   /note="Phosphoserine; by host"
FT                   /evidence="ECO:0000250|UniProtKB:Q01403"
FT   MOD_RES         99
FT                   /note="Phosphoserine; by host"
FT                   /evidence="ECO:0000250|UniProtKB:Q01403"
FT   MOD_RES         116
FT                   /note="Phosphoserine; by host PKA"
FT                   /evidence="ECO:0000250|UniProtKB:Q01403"
FT   MOD_RES         2069
FT                   /note="Phosphotyrosine; by host"
FT                   /evidence="ECO:0000269|PubMed:30862675"
FT   MOD_RES         2198
FT                   /note="Phosphoserine; by host; in p56"
FT                   /evidence="ECO:0000269|PubMed:26874015,
FT                   ECO:0000269|PubMed:28446668"
FT   MOD_RES         2201
FT                   /note="Phosphoserine; by host; in p58"
FT                   /evidence="ECO:0000250|UniProtKB:P26662"
FT   MOD_RES         2205
FT                   /note="Phosphoserine; by host; in p56 and p58, regulates
FT                   intracellular NS5A distribution"
FT                   /evidence="ECO:0000269|PubMed:30089697,
FT                   ECO:0000269|PubMed:31511391"
FT   MOD_RES         2208
FT                   /note="Phosphoserine; by host; in p58"
FT                   /evidence="ECO:0000269|PubMed:28446668,
FT                   ECO:0000269|PubMed:30089697, ECO:0000269|PubMed:31511391"
FT   MOD_RES         2211
FT                   /note="Phosphoserine; by host; in p58"
FT                   /evidence="ECO:0000269|PubMed:26874015,
FT                   ECO:0000269|PubMed:28446668, ECO:0000269|PubMed:30089697,
FT                   ECO:0000269|PubMed:31511391"
FT   MOD_RES         2214
FT                   /note="Phosphoserine; by host; in p58"
FT                   /evidence="ECO:0000269|PubMed:31511391"
FT   MOD_RES         2324
FT                   /note="Phosphothreonine; by host"
FT                   /evidence="ECO:0000269|PubMed:26874015"
FT   LIPID           926
FT                   /note="S-palmitoyl cysteine; by host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   LIPID           1972
FT                   /note="S-palmitoyl cysteine; by host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   LIPID           1976
FT                   /note="S-palmitoyl cysteine; by host; partial"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        196
FT                   /note="N-linked (GlcNAc...) asparagine; by host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        209
FT                   /note="N-linked (GlcNAc...) asparagine; by host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        234
FT                   /note="N-linked (GlcNAc...) asparagine; by host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        305
FT                   /note="N-linked (GlcNAc...) asparagine; by host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        417
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        423
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        430
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        448
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        477
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        534
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        542
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        558
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        578
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        627
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CARBOHYD        649
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   DISULFID        429..554
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   DISULFID        452..459
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   DISULFID        488..496
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   DISULFID        505..510
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   DISULFID        566..571
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   DISULFID        585..589
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   DISULFID        601..624
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   DISULFID        611..648
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   DISULFID        656..681
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   CROSSLNK        2350
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P27958"
FT   MUTAGEN         1322
FT                   /note="C->A: Cleaves ATP 50% slower and unwinds DNA 18%
FT                   more slowly."
FT                   /evidence="ECO:0000269|PubMed:30281972"
FT   MUTAGEN         1322
FT                   /note="C->G: No effect on NS3 helicase activity; 50%
FT                   decreased in nucleic acid binding; decreases the affinity
FT                   of NS3 helicase for Mg2+ by 2 orders of magnitude."
FT                   /evidence="ECO:0000269|PubMed:30281972"
FT   MUTAGEN         2011
FT                   /note="P->A: Slight reduction in infectivity."
FT                   /evidence="ECO:0000269|PubMed:29352312"
FT   MUTAGEN         2019
FT                   /note="Y->A: Complete loss of viral replication."
FT                   /evidence="ECO:0000269|PubMed:29352312"
FT   MUTAGEN         2021
FT                   /note="G->A: Complete loss of viral replication."
FT                   /evidence="ECO:0000269|PubMed:29352312"
FT   MUTAGEN         2023
FT                   /note="W->A: Complete loss of viral replication."
FT                   /evidence="ECO:0000269|PubMed:29352312"
FT   MUTAGEN         2027
FT                   /note="G->A: Complete loss of viral replication."
FT                   /evidence="ECO:0000269|PubMed:29352312"
FT   MUTAGEN         2035
FT                   /note="C->A: Complete loss of viral replication."
FT                   /evidence="ECO:0000269|PubMed:29352312"
FT   MUTAGEN         2036
FT                   /note="G->A: Complete loss of viral replication."
FT                   /evidence="ECO:0000269|PubMed:29352312"
FT   MUTAGEN         2043
FT                   /note="V->A: Complete loss of virus production. Disrupts
FT                   the dimerization and localization of NS5A to lipid
FT                   droplets. NS5A binding to HCV 3'UTRRNA."
FT                   /evidence="ECO:0000269|PubMed:29352312"
FT   MUTAGEN         2072
FT                   /note="G->A: Complete loss of viral replication."
FT                   /evidence="ECO:0000269|PubMed:29352312"
FT   MUTAGEN         2110
FT                   /note="T->A: Complete loss of viral replication."
FT                   /evidence="ECO:0000269|PubMed:29352312"
FT   MUTAGEN         2121
FT                   /note="P->A: Complete loss of virus production. Disrupts
FT                   the dimerization and localization of NS5A to lipid
FT                   droplets. Increased affinity of NS5A binding to HCV
FT                   3'UTRRNA."
FT                   /evidence="ECO:0000269|PubMed:29352312"
FT   MUTAGEN         2205
FT                   /note="S->A: Complete loss of phosphorylation at S-2205,
FT                   S-2208 and S-2211."
FT                   /evidence="ECO:0000269|PubMed:28446668"
FT   MUTAGEN         2208
FT                   /note="S->A: Complete loss of phosphorylation at S-2208 and
FT                   S-2211."
FT                   /evidence="ECO:0000269|PubMed:28446668"
FT   MUTAGEN         2211
FT                   /note="S->A: Complete loss of phosphorylation of S-2211.
FT                   Increases phosphorylation of S-2205. Complete loss of
FT                   infectivity."
FT                   /evidence="ECO:0000269|PubMed:26874015,
FT                   ECO:0000269|PubMed:31511391"
FT   MUTAGEN         2211
FT                   /note="S->D: Alters virus-induced membrane rearrangements,
FT                   no effect on virus infectivity."
FT                   /evidence="ECO:0000269|PubMed:26874015"
FT   MUTAGEN         2292
FT                   /note="D->E: No loss of its RNA-binding ability or
FT                   interaction with human PPIA/CYPA but loss of
FT                   PPIA/CYPA-mediated stimulation of its RNA-binding ability;
FT                   alone or when associated with N-2293."
FT                   /evidence="ECO:0000269|PubMed:21593166"
FT   MUTAGEN         2293
FT                   /note="Y->N: No loss of its RNA-binding ability or
FT                   interaction with human PPIA/CYPA but loss of
FT                   PPIA/CYPA-mediated stimulation of its RNA-binding ability;
FT                   when associated with E-2292."
FT                   /evidence="ECO:0000269|PubMed:21593166"
FT   MUTAGEN         2324
FT                   /note="T->A,D: No effect on viral replication and virus
FT                   production."
FT                   /evidence="ECO:0000269|PubMed:26874015"
FT   MUTAGEN         2428..2433
FT                   /note="SWSTCS->AWATCA: Complete loss of interaction with
FT                   mature core protein."
FT                   /evidence="ECO:0000269|PubMed:18524832"
FT   MUTAGEN         2428..2430
FT                   /note="SWS->EWE: No effect on the interaction with mature
FT                   core protein."
FT                   /evidence="ECO:0000269|PubMed:18524832"
FT   HELIX           175..185
FT                   /evidence="ECO:0007829|PDB:2LIF"
FT   HELIX           189..194
FT                   /evidence="ECO:0007829|PDB:2LIF"
FT   HELIX           537..541
FT                   /evidence="ECO:0007829|PDB:5NPJ"
FT   HELIX           692..701
FT                   /evidence="ECO:0007829|PDB:2KZQ"
FT   TURN            702..706
FT                   /evidence="ECO:0007829|PDB:2KZQ"
FT   HELIX           710..714
FT                   /evidence="ECO:0007829|PDB:2KZQ"
FT   TURN            715..718
FT                   /evidence="ECO:0007829|PDB:2KZQ"
FT   HELIX           1719..1748
FT                   /evidence="ECO:0007829|PDB:2LVG"
FT   STRAND          2444..2448
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2467..2470
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2476..2478
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2479..2481
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2484..2486
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2487..2494
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2504..2517
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2527..2532
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2542..2544
FT                   /evidence="ECO:0007829|PDB:5TWM"
FT   HELIX           2547..2552
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2557..2570
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2572..2574
FT                   /evidence="ECO:0007829|PDB:2XXD"
FT   STRAND          2578..2582
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2586..2588
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2591..2593
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2601..2604
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2607..2629
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2630..2632
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2634..2636
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2639..2651
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2653..2663
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2666..2669
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2672..2684
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2689..2701
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   TURN            2702..2704
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2706..2709
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2715..2719
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2729..2748
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2754..2758
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2761..2767
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2771..2787
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2792..2794
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2799..2801
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2802..2804
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2810..2816
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2818..2820
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2822..2828
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2831..2842
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2846..2849
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2850..2856
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   TURN            2857..2859
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2861..2865
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2867..2878
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2881..2883
FT                   /evidence="ECO:0007829|PDB:4E76"
FT   STRAND          2885..2889
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2892..2896
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2898..2900
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2901..2909
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2911..2914
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2921..2934
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2939..2955
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2958..2967
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2969..2971
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   STRAND          2972..2974
FT                   /evidence="ECO:0007829|PDB:4WTL"
FT   HELIX           2982..2986
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2992..2996
FT                   /evidence="ECO:0007829|PDB:2XYM"
FT   HELIX           2998..3000
FT                   /evidence="ECO:0007829|PDB:4AEP"
FT   STRAND          3002..3004
FT                   /evidence="ECO:0007829|PDB:5TWM"
SQ   SEQUENCE   3033 AA;  328828 MW;  7E5BEA79702AF95B CRC64;
     MSTNPKPQRK TKRNTNRRPE DVKFPGGGQI VGGVYLLPRR GPRLGVRTTR KTSERSQPRG
     RRQPIPKDRR STGKAWGKPG RPWPLYGNEG LGWAGWLLSP RGSRPSWGPT DPRHRSRNVG
     KVIDTLTCGF ADLMGYIPVV GAPLSGAARA VAHGVRVLED GVNYATGNLP GFPFSIFLLA
     LLSCITVPVS AAQVKNTSSS YMVTNDCSND SITWQLEAAV LHVPGCVPCE RVGNTSRCWV
     PVSPNMAVRQ PGALTQGLRT HIDMVVMSAT FCSALYVGDL CGGVMLAAQV FIVSPQYHWF
     VQECNCSIYP GTITGHRMAW DMMMNWSPTA TMILAYVMRV PEVIIDIVSG AHWGVMFGLA
     YFSMQGAWAK VIVILLLAAG VDAGTTTVGG AVARSTNVIA GVFSHGPQQN IQLINTNGSW
     HINRTALNCN DSLNTGFLAA LFYTNRFNSS GCPGRLSACR NIEAFRIGWG TLQYEDNVTN
     PEDMRPYCWH YPPKPCGVVP ARSVCGPVYC FTPSPVVVGT TDRRGVPTYT WGENETDVFL
     LNSTRPPQGS WFGCTWMNST GFTKTCGAPP CRTRADFNAS TDLLCPTDCF RKHPDATYIK
     CGSGPWLTPK CLVHYPYRLW HYPCTVNFTI FKIRMYVGGV EHRLTAACNF TRGDRCDLED
     RDRSQLSPLL HSTTEWAILP CTYSDLPALS TGLLHLHQNI VDVQYMYGLS PAITKYVVRW
     EWVVLLFLLL ADARVCACLW MLILLGQAEA ALEKLVVLHA ASAANCHGLL YFAIFFVAAW
     HIRGRVVPLT TYCLTGLWPF CLLLMALPRQ AYAYDAPVHG QIGVGLLILI TLFTLTPGYK
     TLLGQCLWWL CYLLTLGEAM IQEWVPPMQV RGGRDGIAWA VTIFCPGVVF DITKWLLALL
     GPAYLLRAAL THVPYFVRAH ALIRVCALVK QLAGGRYVQV ALLALGRWTG TYIYDHLTPM
     SDWAASGLRD LAVAVEPIIF SPMEKKVIVW GAETAACGDI LHGLPVSARL GQEILLGPAD
     GYTSKGWKLL APITAYAQQT RGLLGAIVVS MTGRDRTEQA GEVQILSTVS QSFLGTTISG
     VLWTVYHGAG NKTLAGLRGP VTQMYSSAEG DLVGWPSPPG TKSLEPCKCG AVDLYLVTRN
     ADVIPARRRG DKRGALLSPR PISTLKGSSG GPVLCPRGHV VGLFRAAVCS RGVAKSIDFI
     PVETLDVVTR SPTFSDNSTP PAVPQTYQVG YLHAPTGSGK STKVPVAYAA QGYKVLVLNP
     SVAATLGFGA YLSKAHGINP NIRTGVRTVM TGEAITYSTY GKFLADGGCA SGAYDIIICD
     ECHAVDATSI LGIGTVLDQA ETAGVRLTVL ATATPPGSVT TPHPDIEEVG LGREGEIPFY
     GRAIPLSCIK GGRHLIFCHS KKKCDELAAA LRGMGLNAVA YYRGLDVSII PAQGDVVVVA
     TDALMTGYTG DFDSVIDCNV AVTQAVDFSL DPTFTITTQT VPQDAVSRSQ RRGRTGRGRQ
     GTYRYVSTGE RASGMFDSVV LCECYDAGAA WYDLTPAETT VRLRAYFNTP GLPVCQDHLE
     FWEAVFTGLT HIDAHFLSQT KQAGENFAYL VAYQATVCAR AKAPPPSWDA MWKCLARLKP
     TLAGPTPLLY RLGPITNEVT LTHPGTKYIA TCMQADLEVM TSTWVLAGGV LAAVAAYCLA
     TGCVSIIGRL HVNQRVVVAP DKEVLYEAFD EMEECASRAA LIEEGQRIAE MLKSKIQGLL
     QQASKQAQDI QPAMQASWPK VEQFWARHMW NFISGIQYLA GLSTLPGNPA VASMMAFSAA
     LTSPLSTSTT ILLNIMGGWL ASQIAPPAGA TGFVVSGLVG AAVGSIGLGK VLVDILAGYG
     AGISGALVAF KIMSGEKPSM EDVINLLPGI LSPGALVVGV ICAAILRRHV GPGEGAVQWM
     NRLIAFASRG NHVAPTHYVT ESDASQRVTQ LLGSLTITSL LRRLHNWITE DCPIPCSGSW
     LRDVWDWVCT ILTDFKNWLT SKLFPKLPGL PFISCQKGYK GVWAGTGIMT TRCPCGANIS
     GNVRLGSMRI TGPKTCMNTW QGTFPINCYT EGQCAPKPPT NYKTAIWRVA ASEYAEVTQH
     GSYSYVTGLT TDNLKIPCQL PSPEFFSWVD GVQIHRFAPT PKPFFRDEVS FCVGLNSYAV
     GSQLPCEPEP DADVLRSMLT DPPHITAETA ARRLARGSPP SEASSSVSQL SAPSLRATCT
     THSNTYDVDM VDANLLMEGG VAQTEPESRV PVLDFLEPMA EEESDLEPSI PSECMLPRSG
     FPRALPAWAR PDYNPPLVES WRRPDYQPPT VAGCALPPPK KAPTPPPRRR RTVGLSESTI
     SEALQQLAIK TFGQPPSSGD AGSSTGAGAA ESGGPTSPGE PAPSETGSAS SMPPLEGEPG
     DPDLESDQVE LQPPPQGGGV APGSGSGSWS TCSEEDDTTV CCSMSYSWTG ALITPCSPEE
     EKLPINPLSN SLLRYHNKVY CTTSKSASQR AKKVTFDRTQ VLDAHYDSVL KDIKLAASKV
     SARLLTLEEA CQLTPPHSAR SKYGFGAKEV RSLSGRAVNH IKSVWKDLLE DPQTPIPTTI
     MAKNEVFCVD PAKGGKKPAR LIVYPDLGVR VCEKMALYDI TQKLPQAVMG ASYGFQYSPA
     QRVEYLLKAW AEKKDPMGFS YDTRCFDSTV TERDIRTEES IYQACSLPEE ARTAIHSLTE
     RLYVGGPMFN SKGQTCGYRR CRASGVLTTS MGNTITCYVK ALAACKAAGI VAPTMLVCGD
     DLVVISESQG TEEDERNLRA FTEAMTRYSA PPGDPPRPEY DLELITSCSS NVSVALGPRG
     RRRYYLTRDP TTPLARAAWE TVRHSPINSW LGNIIQYAPT IWVRMVLMTH FFSILMVQDT
     LDQNLNFEMY GSVYSVNPLD LPAIIERLHG LDAFSMHTYS HHELTRVASA LRKLGAPPLR
     VWKSRARAVR ASLISRGGKA AVCGRYLFNW AVKTKLKLTP LPEARLLDLS SWFTVGAGGG
     DIFHSVSRAR PRSLLFGLLL LFVGVGLFLL PAR
//
